Melissa Lamar1,2, Sue Leurgans1,3, Alifiya Kapasi1,4, Lisa L Barnes1,2,3, Patricia A Boyle1,2, David A Bennett1,3, Konstantinos Arfanakis1,5,6, Julie A Schneider1,3,4. 1. Rush Alzheimer's Disease Center (M.L., S.L., A.K., L.L.B., P.A.B., D.A.B., K.A., J.A.S.), Rush University Medical Center, Chicago, IL. 2. Department of Psychiatry and Behavioral Sciences (M.L., L.L.B., P.A.B.), Rush University Medical Center, Chicago, IL. 3. Department of Neurological Sciences (S.L., L.L.B., D.A.B., J.A.S.), Rush University Medical Center, Chicago, IL. 4. Department of Pathology (A.K., J.A.S.), Rush University Medical Center, Chicago, IL. 5. Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, Chicago, IL. 6. Department of Biomedical Engineering, Illinois Institute of Technology, Chicago (K.A.).
Abstract
BACKGROUND AND PURPOSE: Cerebrovascular disease (CVD) pathologies including vessel disease (atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy) and tissue injury (macroinfarcts and microinfarcts) each contribute to Alzheimer and other forms of dementia. CVD is often a complex mix of neuropathologies, with little known about the frequencies of differing combinations or their associations with cognition. METHODS: We investigated 32 possible CVD combinations (3 types of vessel disease and 2 types of tissue injury) using autopsy data from 1474 decedents (≈88 years at death; 65% female) of Rush Alzheimer's Disease Center studies. We determined frequencies of all 32 CVD combinations and their relationships with global and domain-specific cognitive decline using mixed-effect models adjusted for demographics, neuropathologies, time before death, and interactions of these variables with time. RESULTS: Of the 1184 decedents with CVD neuropathology (80% of the total sample), 37% had a single CVD (67-148 decedents/group) while 63% had mixed CVD profiles (11-54 decedents/group). When considered as 2 distinct groups, the mixed CVD profile group (but not the single CVD profile group) showed a faster cognitive decline across all domains assessed compared with decedents without CVD neuropathology. Most mixed CVD profiles, especially those involving both atherosclerosis and arteriolosclerosis, showed faster cognitive decline than any single CVD profile considered alone; specific mixed CVD profiles differentially associated with individual cognitive domains. CONCLUSIONS: Mixed CVD, more common than single CVD, is associated with cognitive decline, and distinct mixed CVD profiles show domain-specific associations with cognitive decline. CVD is not monolithic but consists of heterogenous person-specific combinations with distinct contributions to cognitive decline.
BACKGROUND AND PURPOSE: Cerebrovascular disease (CVD) pathologies including vessel disease (atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy) and tissue injury (macroinfarcts and microinfarcts) each contribute to Alzheimer and other forms of dementia. CVD is often a complex mix of neuropathologies, with little known about the frequencies of differing combinations or their associations with cognition. METHODS: We investigated 32 possible CVD combinations (3 types of vessel disease and 2 types of tissue injury) using autopsy data from 1474 decedents (≈88 years at death; 65% female) of Rush Alzheimer's Disease Center studies. We determined frequencies of all 32 CVD combinations and their relationships with global and domain-specific cognitive decline using mixed-effect models adjusted for demographics, neuropathologies, time before death, and interactions of these variables with time. RESULTS: Of the 1184 decedents with CVD neuropathology (80% of the total sample), 37% had a single CVD (67-148 decedents/group) while 63% had mixed CVD profiles (11-54 decedents/group). When considered as 2 distinct groups, the mixed CVD profile group (but not the single CVD profile group) showed a faster cognitive decline across all domains assessed compared with decedents without CVD neuropathology. Most mixed CVD profiles, especially those involving both atherosclerosis and arteriolosclerosis, showed faster cognitive decline than any single CVD profile considered alone; specific mixed CVD profiles differentially associated with individual cognitive domains. CONCLUSIONS: Mixed CVD, more common than single CVD, is associated with cognitive decline, and distinct mixed CVD profiles show domain-specific associations with cognitive decline. CVD is not monolithic but consists of heterogenous person-specific combinations with distinct contributions to cognitive decline.
Authors: Patricia A Boyle; Jingyun Yang; Lei Yu; Sue E Leurgans; Ana W Capuano; Julie A Schneider; Robert S Wilson; David A Bennett Journal: Brain Date: 2017-03-01 Impact factor: 13.501
Authors: Ali Ezzati; Cuiling Wang; Richard B Lipton; Dorothea Altschul; Mindy J Katz; Dennis W Dickson; Carol A Derby Journal: J Am Geriatr Soc Date: 2017-04-13 Impact factor: 5.562
Authors: Claudia H Kawas; Ronald C Kim; Joshua A Sonnen; Szofia S Bullain; Thomas Trieu; María M Corrada Journal: Neurology Date: 2015-07-15 Impact factor: 9.910
Authors: Zhaolu Wang; Susanne J van Veluw; Adrian Wong; Wenyan Liu; Lin Shi; Jie Yang; Yunyun Xiong; Alexander Lau; Geert Jan Biessels; Vincent C T Mok Journal: Stroke Date: 2016-08-18 Impact factor: 7.914
Authors: Zoe Arvanitakis; Ana W Capuano; Sue E Leurgans; Aron S Buchman; David A Bennett; Julie A Schneider Journal: Brain Pathol Date: 2016-04-14 Impact factor: 6.508
Authors: Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling Journal: Alzheimers Dement Date: 2018-04 Impact factor: 21.566
Authors: Zoe Arvanitakis; Ana W Capuano; Sue E Leurgans; David A Bennett; Julie A Schneider Journal: Lancet Neurol Date: 2016-06-14 Impact factor: 44.182